Jump to content

MindMed thinks they've found an Emergency Off-Switch (ketanserin) for Psychedelics


Recommended Posts

https://psilocybinalpha.com/news/mindmeds-lsd-neutralizer-study-begins

'MindMed has commenced a study for its “LSD neutralizer technology,” which it hopes will be effective in shortening and even stopping the effects of an LSD trip during LSD assisted therapy sessions.

In collaboration with the Liechti Lab at University Hospital Basel, a Phase 1 clinical trial will evaluate the effect of ketanserin for this purpose.

MindMed hopes the study will be completed by the end of 2021.'

 

  • Like 2
Link to post
Share on other sites

...thank you...fascinating....can see as an important tool in psychotherapy... but begs the question, and another study....does it also block the beneficial effects for CH?

....still, without availability of bol-148, a potential option....

  • Like 1
Link to post
Share on other sites

Hmmm.....is it an un-buster? That would be a good question. I have the feeling we'd be left trying to figure that out ourselves for a good while before any psychedelic / ketanserin / CH study would be undertaken.

  • Like 2
Link to post
Share on other sites

...yeah, i know, it aint gonna happen officially.  we've pretty much always been on our own...or what's a Clusterbusters for? citizen science that DECADES down the line might get a mention like "yeah those alt medicine cluster folks were onto something".....................

  • Like 2
Link to post
Share on other sites

Mindmend is poking the bear with provocative statements.  The skeptical cynical me says they are throwing out info to create investor support.  Not bad in and of itself.  I do not care for the proprietary approach several of these concerns are taking.  I know they have investments to protect but they are patenting molecules and ideas that have been around a long time.  Right now they are throwing a lot of stuff in the air to see what sticks and generate interest. 

MAPS has been at this much longer and seems to be a more inclusive route. 

Any of this type of research is a long way from clinical application.  At least its getting done.. 

  • Like 1
Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...